Long-Term Planning: Our team discusses long-term considerations, including monitoring, financial aspects, and exploring insurance coverage
A small study of eight women taking injectable semaglutide (Ozempic, Wegovy) found no detectable drug in their breast milk, though this sample size is too small to draw broad conclusions
Common GLP-1 medications prescribed in 2025 include: Semaglutide (Wegovy, Ozempic) Tirzepatide (Mounjaro) Liraglutide (Saxenda) Peer-reviewed clinical trials published in journals such as The New England Journal of Medicine and JAMA document average body weight reductions of approximately 1022% over 612 months when GLP-1 medications are combined with lifestyle support and ongoing physician oversight
Redox Biol 15:490503 Mariani E, Polidori MC, Cherubini A et al (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview [J]
Just as weight gain takes time, so does weight loss